NCT04435509: TEAMENTIA

Management of Mild Cognitive Impairment Patients With Greek Mountain Tea - TEAMENTIA

Status unknown NA Last updated 17 June 2020

What this trial tests

NA trial testing 1000+ Greek Mountain Tea in Mild Cognitive Impairment in 50 participants. Status unknown.

Timeline

17 November 2019

Primary endpoint
30 September 2020

30 May 2021

Quick facts

Lead sponsor	Aristotle University Of Thessaloniki
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	17 November 2019
Primary completion	30 September 2020
Estimated completion	30 May 2021
Sites	1 location across Greece

Drugs / interventions tested

• 1000+ Greek Mountain Tea
• Mediterranean Diet

Conditions studied

• Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Aristotle University Of Thessaloniki

Who can join

Adults 55 to 85, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is accumulating evidence suggesting that Greek Mountain Tea may have a positive impact on conditions involving cognitive deficits, such as Mild Cognitive Impairment (MCI) and AD. More specifically, greek mountain olympos tee is rich in essential oils, flavonoids, diterpenes and phenylpropanes, which are primarily responsible for its pharmacological properties. Its confirmed antioxidant properties are what make mountain tea promising against Alzheimer's disease and other neurodegenerative diseases. It has also been proven to possess cholinergic and cognitive enhancing capabilities. Greek Mountain Tea is deeper studied and it shows promising results in neuroprotection against AD through various suggested mechanisms, such as the enhancement of amyloid-beta clearance in the brain and the inhibition of neurofibrillary tangles formation. The aim of the study is to evaluate the beneficial effect of Greek Mountain Tea in patients diagnosed with mild cognitive impairment MCI.

Study Type: Interventional Study Design: Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Prevention

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Management and Prevention of Neurodegenerative Disorders: Can Antioxidant-Rich Dietary Interventions Help?
   Nagpal D, Nema S, Nagpal S, Pandey MM, et al · · 2025 · cited 2× · PMID 41008984 · DOI 10.3390/antiox14091078